About KLAS
KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com, e-mail marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative. ©[<00A9>][<00A9>]2011 KLAS Enterprises, LLC. All rights reserved.

Ad Statistics
Times Displayed: 23276
Times Visited: 503 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
1. "Oncology IS 2011: Integrating the Island," August, 2011. ©[<00A9>][<00A9>] 2011 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com
2. Varian's ARIA software ranked #1 in KLAS's annual survey in 2008, 2009, and 2011.
Back to HCB News